Selective regulation of β1-and β2-adrenoceptors in the human heart by chronic β-adrenoceptor antagonist treatment-Reference-Cited by-同舟云学术

Selective regulation of β1-and β2-adrenoceptors in the human heart by chronic β-adrenoceptor antagonist treatment

Published:1988-07 Issue:3 Volume:94 Page:685-692
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Michel M.C.,Pingsmann A.,Beckeringh J.J.,Zerkowski H.-R.,Doetsch N.,Brodde O.-E.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1988.tb11576.x/fullpdf

Reference37 articles.

1. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol;AARONS;J. Pharmacol. Exp. Ther,1982

2. Elevation of β-adrenergic receptor density in human lymphocytes after propranolol administration;AARONS;J. Clin. Invest,1980

3. The pharmacology of a β2-selective adrenoceptor antagonist (ICI 118,551);BILSKI;J. Cardiovasc. Pharmacol,1983

4. Isolation of mononuclear cells and granulocytes from human blood;BÖYUM;Scand. J. Clin. Lab. Invest,1968

5. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human heart;BRISTOW;N. Engl. J. Med,1982

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β-blockers Reverse Agonist-Induced β2-AR Downregulation Regardless of Their Signaling Profile;International Journal of Molecular Sciences;2020-01-14

2. Prevention of pancreatic cancer in a hamster model by cAMP decrease;Oncotarget;2016-06-02

3. Assessment of the Effects of Age, Gender, and Exercise Training on the Cardiac Sympathetic Nervous System Using Positron Emission Tomography Imaging;The Journals of Gerontology Series A: Biological Sciences and Medical Sciences;2016-03-08

4. Modeling the Effects of β1-Adrenergic Receptor Blockers and Polymorphisms on Cardiac Myocyte Ca2+ Handling;Molecular Pharmacology;2014-05-27

5. Oral Terbutaline in Replacement for Intravenous Dopamine in a Patient with End-Stage Heart Failure;Annals of Pharmacotherapy;2013-04